These data validate OTUD6B as a new oncogene, dependency, and prognostic factor in MM that determines MYC activity in MM patients and may contribute to the conversion of premalignant MGUS state to the proliferative MM state. This evidence concerns the gene OTUD6B and Miyoshi myopathy.